ARYx Therapeutics Financial Ratios for Analysis 2009-2024 | ARYX

Fifteen years of historical annual and quarterly financial ratios and margins for ARYx Therapeutics (ARYX).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2009
1.01
2.23
-3.59
-
-
-
-
-
-
-
-
-
-
1,137
1,137
-267.35
-1,401.23
-0.10
-1.27
-1.28

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
0.470.361.001.011.522.293.44
-1.59-1.502.182.370.780.430.35
-1.50-1.16-3.55-3.337.251.560.81
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
32.5061.28266198-448.79-100.34-54.62
32.5061.28266198-448.79-100.34-54.62
-42.10-72.46-60.43-48.33-42.26-33.71-25.23
84.16153-314.47-272.20-99.57-56.97-35.42
-0.23-0.18-0.07-0.100.070.340.66
-0.42-0.30-0.22-1.27-1.05-0.81-0.43
-0.42-0.30-0.22-1.28-1.06-0.81-0.43